Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

231.70
Delayed Data
As of Jan 20
 +1.94 / +0.84%
Today’s Change
216.45
Today|||52-Week Range
270.00
+1.65%
Year-to-Date
Bristol-Myers Squibb, Where Art Thou? Not in First-Line Lung Cancer Immunotherapy, Sa...
Jan 20 / TheStreet.com - Paid Partner Content
1 Perfect Stock to Invest in the Pharmaceutical Industry
Jan 10 / MotleyFool.com - Paid Partner Content
Merck KGaA Expands Distribution Deal with Roche (revised)
Jan 17 / Zacks.com - Paid Partner Content
Roche Gets Priority Review for Immunotherapy Drug Tecentriq
Jan 10 / Zacks.com - Paid Partner Content
Better Buy: Novavax, Inc. vs. Roche
Jan 16 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regen...
Jan 10 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News
Jan 13 / Zacks.com - Paid Partner Content
The FDA Approved Fewer Drugs in 2016: Here's Why
Jan 09 / Zacks.com - Paid Partner Content
Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.
Jan 12 / Zacks.com - Paid Partner Content
Could This Be Why Pacific Biosciences of California Stock Climbed Today?
Jan 03 / MotleyFool.com - Paid Partner Content
Bristol-Myers and AstraZeneca Take Beatings
Jan 11 / TheStreet.com - Paid Partner Content
Is It Too Late to Buy Exelixis Stock?
Jan 03 / MotleyFool.com - Paid Partner Content
3 Charts Every Bristol-Myers Squibb Shareholder Needs to See
Jan 11 / MotleyFool.com - Paid Partner Content